This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Lymphoedema is a chronic progressive disease (1).

It is characterized by swelling of the limbs (usually with involvement of the fingers) which is firm and pits poorly (2).

In the early stages of the disease there can be pitting oedema followed by fibrosis and finally irreversible swelling (1). Fibrosis particularly affects the toes and dorsum of the foot The swelling may be limited to either the proximal or the distal segment of the limb (2).

The condition is often longstanding.

One or more limbs may be affected.

Female patients of all age groups constitute 65 - 70 % of cases of primary lymphoedema.

Kaposi-Stemmer sign - inability to pinch a fold of skin on the dorsal surface of the foot at the base of the second toe is a sign of lymphedema (3).

Other than swelling patients may present with a wide variety of complaints:

  • heaviness or fullness of the limb
  • a tight sensation of the skin
  • decreased ambulation of the affected limb
  • patient may find it difficult to fit the affected area into clothing or wearing previously well-fitting rings, watches or shoes
  • sleep disturbances (2)

Lymphoedema may lead to recurrent skin infection (cellulitis) which results in further damage to the lymphatic vessels and progression of the disease (1).

Reference:

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.